Brander C, Hartman K E, Trocha A K, Jones N G, Johnson R P, Korber B, Wentworth P, Buchbinder S P, Wolinsky S, Walker B D, Kalams S A
AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
J Clin Invest. 1998 Jun 1;101(11):2559-66. doi: 10.1172/JCI2405.
Despite detailed analysis of the HIV-1-specific cytotoxic T lymphocyte response by various groups, its relation to viral load and viral sequence variation remains controversial. We analyzed HLA-A0201 restricted cytotoxic T lymphocyte responses in 17 HIV-1-infected individuals with viral loads ranging from < 400 to 221,000 HIV RNA molecules per milliliter of plasma. In 13 out of 17 infected subjects, CTL responses against the SLYNTVATL epitope (p17 Gag; aa 77-85) were detectable, whereas two other HLA-A0201 restricted epitopes (ILKEPVHGV, IV9; and VIYQYMDDL, VL9) were only recognized by six and five individuals out of 17 individuals tested, respectively. Naturally occurring variants of the SL9 epitope were tested for binding to HLA-A0201 and for recognition by specific T cell clones generated from five individuals. Although these variants were widely recognized, they differed by up to 10,000-fold in terms of variant peptide concentrations required for lysis of target cells. A comparison of viral sequences derived from 10 HLA-A0201-positive individuals to sequences obtained from 11 HLA-A*0201-negative individuals demonstrated only weak evidence for immune selective pressure and thus question the in vivo efficacy of immunodominant CTL responses present during chronic HIV-1 infection.
尽管多个研究小组对HIV-1特异性细胞毒性T淋巴细胞反应进行了详细分析,但其与病毒载量和病毒序列变异之间的关系仍存在争议。我们分析了17名HIV-1感染者中HLA-A0201限制性细胞毒性T淋巴细胞反应,这些感染者的病毒载量范围为每毫升血浆中<400至221,000个HIV RNA分子。在17名受感染受试者中的13名中,可检测到针对SLYNTVATL表位(p17 Gag;氨基酸77 - 85)的CTL反应,而另外两个HLA-A0201限制性表位(ILKEPVHGV,IV9;和VIYQYMDDL,VL9)在17名受试个体中分别仅被6人和5人识别。对SL9表位的天然变异体进行了与HLA-A0201结合的测试以及由5名个体产生的特异性T细胞克隆的识别测试。尽管这些变异体被广泛识别,但在裂解靶细胞所需的变异肽浓度方面,它们的差异高达10,000倍。将来自10名HLA-A0201阳性个体的病毒序列与11名HLA-A*0201阴性个体的序列进行比较,仅显示出微弱的免疫选择压力证据,因此对慢性HIV-1感染期间存在的免疫显性CTL反应的体内疗效提出了质疑。